GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up | Ben Fidler | 08/11/17 | San Diego |
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More | Alex Lash | 07/21/17 | National |
Akcea Slashes IPO Price Ahead of Filing for Rare Disease Drug | Frank Vinluan | 07/14/17 | Boston |
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More | Ben Fidler | 03/31/17 | National |
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO | Frank Vinluan | 03/27/17 | Boston |